Register Cart 0

Generic placeholder image

Inflammation & Allergy - Drug Targets (Discontinued)

Editor-in-Chief

ISSN (Print): 1871-5281
ISSN (Online): 2212-4055

Back Subscribe

Preface

Author(s): Prem L. Bhalla and Mohan B. Singh

Volume 5, Issue 1, 2006

Page: [i - i] Pages: 1

DOI: 10.2174/187152806775269268

Price: $65

« Previous

Rights & Permissions Print Cite

Article Metrics

9

Related Articles

Radiopharmaceuticals, Drug Development and Pharmaceutical Regulations in Europe
Current Radiopharmaceuticals

Oxidative Stress and Transforming Growth Factor-β<sub>1</sub>-induced Cardiac Fibrosis
Cardiovascular & Hematological Disorders-Drug Targets

Anti-metastatic Treatment in Colorectal Cancer: Targeting Signaling Pathways
Current Pharmaceutical Design

Patient, Disease, and Drug-Related Risk Factors Associated with Phenytoin- Induced Cutaneous Adverse Drug Reactions in South Indian Epileptic Patients - A Prospective Case-Control Study
Current Drug Safety

Understanding Functional Residues of the Cannabinoid CB1 Receptor for Drug Discovery
Current Topics in Medicinal Chemistry

Protective Effect of Alpha-Tocopherol in Deltamethrin Induced Immunotoxicity
Endocrine, Metabolic & Immune Disorders - Drug Targets

Patent Annotations
Recent Patents on Anti-Infective Drug Discovery

Lipoxygenase: An Emerging Target for Stroke Therapy
CNS & Neurological Disorders - Drug Targets

Synthesis, Reactions and Biological Evaluation of 3-Amino-6- (subs.)thieno[2,3-b]pyridine-2-carbohydrazides
Current Bioactive Compounds

Cytokines and Chemokines as Regulators of Angiogenesis in Health and Disease
Current Pharmaceutical Design

Prolylcarboxypeptidase Gene Expression in the Heart and Kidney: Effects of Obesity and Diabetes
Cardiovascular & Hematological Agents in Medicinal Chemistry

Editorial [Hot Topic: Regulation of Pathogenetic Aspects of Allergic Diseases (Guest Editor: Lydie Izakovicova Holla)]
Current Drug Targets - Inflammation & Allergy

Activation of p53 by Specific Agents in Potential Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents

EPO Relies upon Novel Signaling of Wnt1 that Requires Akt1, FoxO3a,GSK-3β, and β-Catenin to Foster Vascular Integrity during Experimental Diabetes
Current Neurovascular Research

Solid Lipid Nanoparticles Containing Nimesulide: Preparation, Characterization and Cytotoxicity Studies
Current Nanoscience

Understanding the Multifaceted Role of Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 (ENPP2) and its Altered Behaviour in Human Diseases
Current Molecular Medicine

Endothelial Dysfunction in Morbid Obesity
Current Pharmaceutical Design

Allogeneic Hematopoietic Stem Cell Transplant for Severe Aplastic Anemia: Current State and Future Directions
Current Stem Cell Research & Therapy

Predicting Drug Efficacy Using Integrative Models for Chronic Respiratory Diseases
Inflammation & Allergy - Drug Targets (Discontinued)

Editorial [Hot topic: Prion Diseases: Targets and Treatments of Symptoms and Disease Progression (Guest Editor: Brian Appleby)]
CNS & Neurological Disorders - Drug Targets

© 2024 Bentham Science Publishers | Privacy Policy